🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $PUB.PA and executed a BUY strategy, securing a +9.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$IFRX

InflaRx NV

United StatesUNITED STATES
FREE PREVIEW
📅 Next Earnings: Aug 06, 2026 ☀️ Open🌐 Website🏛️ NASDAQ📁 Health Technology🏭 Biotechnology
AVG HISTORICAL GAP2.52%
MAX GAP RECORD43.90%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY10.5%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab. The company was founded by Niels Christoph Riedemann, Renfeng Guo, and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL